Watch Demo

Cancer Diagnostics Market Shares and Sales Forecasts by Test and Country, Competitive Landscape, 2019-2023

Cancer Diagnostics Market Shares and Sales Forecasts by Test and Country, Competitive Landscape, 2019-2023

  • Publish Date:July 2019

  • Number of Pages:104

  • Report ID:5792133

  • Format:PDF

  • Publisher:Venture Planning Group

$ 750

Summary

Cancer Diagnostics Market Shares and Sales Forecasts by Test and Country, Competitive Landscape, 2019-2023

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.

Contains 104 pages and 3 tables


Companies Profiled
Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

Table of contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.